How many insider trades does FilingIQ track for KOD?

FilingIQ tracks 451 Form 4 insider transactions for KOD (Kodiak Sciences Inc.), covering filings from Oct 9, 2018 onwards. 11 of those were filed in the last 90 days.

Are KOD insiders net buyers or net sellers?

Across the full Form 4 history for KOD, 228 transactions (51%) were open-market purchases and 150 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does KOD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is KOD in?

Kodiak Sciences Inc. (KOD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.38B.

KOD insider trading

NasdaqGM Healthcare

Kodiak Sciences Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

451

Last 90 days

Buys / sells

51% / 33%

Market cap

$1.38B

About Kodiak Sciences Inc.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Company website: kodiak.com

KOD insider activity at a glance

FilingIQ has scored 451 insider transactions for KOD since Oct 9, 2018. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 228 open-market purchases and 150 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on KOD insider trades is 47.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live KOD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for KOD?: FilingIQ tracks 451 Form 4 insider transactions for KOD (Kodiak Sciences Inc.), covering filings from Oct 9, 2018 onwards. 11 of those were filed in the last 90 days.
Are KOD insiders net buyers or net sellers?: Across the full Form 4 history for KOD, 228 transactions (51%) were open-market purchases and 150 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does KOD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is KOD in?: Kodiak Sciences Inc. (KOD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.38B.

Methodology & sources

Every KOD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.